Sector portfolio · Investment firm
JJDC's Biotech portfolio
JJDC has backed 10 Biotech startups in rounds we track, $824M between them, shown by the stage each has reached. The best-funded is T-Therapeutics.
Funding by segment
- Series A$101M3
- Series C and later$346M3
- Stage not reported$54M2
- Series B$324M2
Where they are based
- United States8$531M
- Germany1$14M
- United Kingdom1$279M
United States
Germany
United KingdomFounded
5 without a founding year on record.
Total raised
- Under $1M0
- $1M to $10M0
- $10M to $50M6
- $50M to $250M3
- $250M to $1B1
- $1B and over0
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
5 of 10 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- United States8
- Germany1
- United Kingdom1
Startups by country, 3 countries in all.
Segment by segment
Series A
3 startups · $101M raised
- XX-VaxUnited States$56M
- MNMagnolia NeuroscienceUnited States$31M
Cara CareCara Care is a digital health platform that offers an app-based treatment to help patients with chronic gastrointestinal problems.Germany$14M
Series C and later
3 startups · $346M raised
ReVision OpticsReVision Optics offers PRESBYLENS, a refractive surgery solution to correct vision loss by the natural aging process.United States$172M
Evolve BioSystemsEvolve Biosystems provides microbiome-based products.United States$124M- PPhaseBioUnited States$50M
Stage not reported
2 startups · $54M raised
- OTOn TargetUnited States$40M
Artizan BiosciencesArtizan Biosciences focuses on drug discovery and development for diseases involving the human intestinal microbiota.United States$14M
Series B
2 startups · $324M raised
T-TherapeuticsT-Therapeutics is a next-generation T cell receptor (TCR) company spun off from the University of Cambridge.United Kingdom$279M- CHCue HealthUnited States$45M
How this map is made. Every startup here works in Biotech and has raised money in a round we track that names JJDC as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosRaising from investors like JJDC?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.